Biotechnology and pharmaceutical companies are working on experimental vaccines to ward off the Epstein-Barr virus, with at least two development efforts in Massachusetts.
Recent leaps in research lend urgency to the quest to develop a vaccine against Epstein-Barr, a ubiquitous virus linked to a range of illnesses, from mononucleosis to multiple sclerosis and several cancers.
Recent leaps in research lend urgency to the quest to develop a vaccine against Epstein-Barr, a ubiquitous virus linked to a range of illnesses, from mononucleosis to multiple sclerosis and several cancers.
Epstein-Barr virus: NIH launches early-stage clinical trial to evaluate investigational preventative vaccine outbreaknewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outbreaknewstoday.com Daily Mail and Mail on Sunday newspapers.